Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Heart failure patient with mid range ejection fraction: who are they?
Session:
Posters 2 - Écran 7 - Insuficiência Cardíaca
Speaker:
Vanessa Novais de Carvalho
Congress:
CPC 2019
Topic:
D. Heart Failure
Theme:
10. Chronic Heart Failure
Subtheme:
10.4 Chronic Heart Failure – Treatment
Session Type:
Posters
FP Number:
---
Authors:
Vanessa Carvalho; João Galaz Tavares; Luís Mão De Ferro Landeiro; Ines Rodrigues; Pedro Moraes Sarmento
Abstract
<p>The most recent ESC Guidelines redefined heart failure classification, introducing a new type according ejection fraction: the heart failure with mid range ejection fraction (HFmrEF) were the ejection fraction ranges from 40 to 50%. No clear recommendations exist on how to treat these patients as few is known about there characteristics.</p> <p>AIMS: To characterize hospitalized heart failure patients with mid range ejection fraction. To evaluate the proportion of this type of heart failure among hospitalized heart failure patients.</p> <p>METHODS: Medical records of all heart failure patients consecutively admitted, between January and December 2017, to a private university hospital were assessed. Demographic data, heart failure type and aetiology, comorbidities, causes of decompensation were evaluated. Ejection fraction was evaluated using echocardiography performed during hospitalization. Patients were classified according ESC guidelines on preserved ejection fraction (>50%), mid range ejection fraction (40-50%) and reduced ejection fraction (<40%).</p> <p>RESULTS: In the study period, 172 patients were admitted for decompensate heart failure. 36 (21%) patients had heart failure with reduced ejection fraction, 100 (58%) with preserved ejection fraction and 36 (21%) with mid range ejection fraction. HFmrEF patients were younger than HFpEF patients (79±11 vs. 82±11 years) but with no difference compared to reduced ejection fraction patients (79±11 vs 79±9 years). Regarding genre distribution (male vs female), there was no difference among HFmrEF patients (18 vs 18), while in HFpEF patients there were more women (35 vs 65) and in HFrEF patients more men (27 vs 9). Regarding comorbidities patients with HFmrHF had more atrial fibrillation than HFpEF and HFrEF patients (20(56%) vs 52 (52%) 13(36%)), less Diabetes 5(14%) vs 27(27%) vs 17(47%)), less ischaemic heart disease 11(31%) vs 25(25%) vs 18(50%)), less hypertension (23(64%) vs 73(73%) vs 27(75%)) and less COPD (7(19%) vs 12(12%) vs 9(25%)). HFmrEF had also a lower NTproBNP (7279±8211 vs 7178±10071 vs 11086±16373 pg/mL) and a lower eGFR MDRD (52,1 vs 61,0 vs 57,0 ml/min/m2) in comparison to HFpEF and HFrEF.</p> <p>CONCLUSIONS: In our real-world hospitalized heart failure population, the prevalence of HFmrHF was 21%. These patients are expected to be younger, with more atrial fibrillation but less other comorbidities than HFpEF and HFrEF patients</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site